AmerisourceBergen Corporation announced that it has signed a new five-year agreement to supply pharmaceuticals to Express Scripts Holding Company. The agreement extends through September 2022. AmerisourceBergen and Express Scripts’ most recent supply agreement began in October 2012 and was set to expire in September 2017. The fiscal year 2016 revenue contribution from that agreement was approximately $23 billion.
“Our businesses are aligned to provide the highest quality service to our pharmacies and the patients we are privileged to serve,” Express Scripts President and CEO Tim Wentworth said. “Together, we are working to deliver more cost-effective pharmacy care, which is needed now more than ever. We are proud to extend our relationship with AmerisourceBergen.”
“We are extremely pleased and proud to continue to be the strategic partner of choice and provide brand pharmaceuticals for Express Scripts,” Steven H. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen said. “AmerisourceBergen works hard to be the best possible partner, providing the highest levels of service and value to our customers and supporting their long-term growth. We believe this new agreement is a result of that dedication and an illustration of our strong customer relationships.”